Physician profile
Yuvraj S Grewal
NPI 1073821922
$6,227.39
in general payments reported to CMS, 2019-2025
47 companies · $953 in 2025
The $953 reported for 2025 was more than what a typical Clinical Neurophysiology provider received nationally (typical 2025 total: $435).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2020: $494 · 2021: $1,241 · 2022: $1,464 · 2023: $1,055 · 2024: $915 · 2025: $953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,911 · Education: $13.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,910.72 |
| Education | $13.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,592.25 | 2021-2025 | |
| Pfizer INC. | $390.15 | 2021-2025 | |
| Biogen, INC. | $361.39 | 2020-2024 | Vumerity, Tysabri |
| Astrazeneca Pharmaceuticals Lp | $351.52 | 2021-2023 | Andexxa, Evusheld |
| Amgen INC. | $340.15 | 2020-2025 | Uplizna |
| Celgene Corporation | $294.16 | 2021-2024 | Zeposia |
| Sk Life Science, INC. | $279.62 | 2020-2023 | |
| Genentech USA, INC. | $208.43 | 2022-2025 | Ocrevus Zunovo, Ocrevus |
| Lilly USA, LLC | $195.21 | 2020-2024 | Emgality, Reyvow |
| Upsher-Smith Laboratories LLC | $165.10 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $150.72 | 2021 | |
| Neurocrine Biosciences, INC. | $132.89 | 2022-2023 | Ingrezza, Ongentys |
| Biohaven Pharmaceutical Holding Company Ltd. | $128.26 | 2022 | |
| Ani Pharmaceuticals, INC. | $107.99 | 2025 | Purified Cortrophin Gel |
| Lundbeck LLC | $107.41 | 2024-2025 | Vyepti |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yuvraj Grewal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.